{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:53:03Z","timestamp":1778356383599,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Steun Emma Kinderziekenhuis AMC"},{"name":"WE Foundation"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bone.2016.01.029","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T02:41:20Z","timestamp":1462070480000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Sandra D.K.","family":"Kingma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wagemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonius L.J.J.","family":"Bronckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toin H.","family":"van Kuppevelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Everts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"van Vlies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.bone.2016.01.029_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford, England)"},{"issue":"Suppl. 5","key":"10.1016\/j.bone.2016.01.029_bb0010","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2016.01.029_bb0015","article-title":"Therapies for the bone in mucopolysaccharidoses","author":"Tomatsu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2016.01.029_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2016.01.029_bb0025","first-page":"122","article-title":"Prenatal pathology in mucopolysaccharidoses: a comparison with postnatal cases","volume":"2","author":"Martin","year":"1983","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.bone.2016.01.029_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.bone.2016.01.029_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and hurler syndrome (MPS-IH)","volume":"30","author":"Ko\u00e7","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bone.2016.01.029_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","article-title":"Developmental regulation of the growth plate","volume":"423","author":"Kronenberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2016.01.029_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:GLYC.0000043747.87325.5e","article-title":"Sulfation pattern in glycosaminoglycan: does it have a code?","volume":"21","author":"Habuchi","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bone.2016.01.029_bb0050","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1242\/dev.030742","article-title":"Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate","volume":"136","author":"Cortes","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.01.029_bb0055","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cell.2008.05.026","article-title":"Nanoscale organization of hedgehog is essential for long-range signaling","volume":"133","author":"Vyas","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.01.029_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2016.01.029_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2016.01.029_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.1998.tb02745.x","article-title":"Murine MPS I: insights into the pathogenesis of Hurler syndrome","volume":"53","author":"Russell","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bone.2016.01.029_bb0075","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M104852200","article-title":"Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies","volume":"277","author":"Dennissen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.029_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.matbio.2006.06.003","article-title":"Selection and characterization of a unique phage display-derived antibody against dermatan sulfate","volume":"25","author":"Lensen","year":"2006","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bone.2016.01.029_bb0085","doi-asserted-by":"crossref","first-page":"19442","DOI":"10.1074\/jbc.M700630200","article-title":"Functions of chondroitin sulfate\/dermatan sulfate chains in brain development: critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7","volume":"282","author":"Purushothaman","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.029_bb0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.0022-202X.2004.22316.x","article-title":"Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis","volume":"122","author":"Smetsers","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bone.2016.01.029_bb0095","doi-asserted-by":"crossref","first-page":"41143","DOI":"10.1074\/jbc.M110.153791","article-title":"The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease","volume":"285","author":"Smits","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.029_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00418-009-0592-2","article-title":"Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas","volume":"132","author":"Ten Dam","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bone.2016.01.029_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2006.05.003","article-title":"Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics","volume":"48","author":"Wijnhoven","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bone.2016.01.029_bb0110","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1074\/jbc.M506357200","article-title":"3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3","volume":"281","author":"Ten Dam","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.029_bb0115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10545-014-9703-x","article-title":"Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models","volume":"37","author":"Kingma","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bone.2016.01.029_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2016.01.029_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4690-3-2","article-title":"Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology","volume":"3","author":"Ruijter","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.bone.2016.01.029_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.01.029_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.01.029_bb0140","doi-asserted-by":"crossref","first-page":"C1387","DOI":"10.1152\/ajpcell.00346.2007","article-title":"Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity","volume":"294","author":"Khan","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bone.2016.01.029_bb0145","doi-asserted-by":"crossref","first-page":"37515","DOI":"10.1074\/jbc.M111.287474","article-title":"Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking \u03b1-l-iduronidase","volume":"286","author":"Holley","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.029_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2016.01.029_bb0155","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2005-02-0657","article-title":"Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells","volume":"106","author":"Pan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bone.2016.01.029_bb0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jcp.1041280317","article-title":"Heparin protects basic and acidic FGF from inactivation","volume":"128","author":"Gospodarowicz","year":"1986","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2016.01.029_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1534-5807(02)00261-7","article-title":"Interaction of FGF, Ihh\/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation","volume":"3","author":"Minina","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.029_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.matbio.2013.12.001","article-title":"Heparan sulfate 3-O-sulfation: a rare modification in search of a function","volume":"35","author":"Thacker","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bone.2016.01.029_bb0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2009.03.008","article-title":"Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients","volume":"97","author":"Bank","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2016.01.029_bb0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2014.09.012","article-title":"Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I","volume":"114","author":"Heppner","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bone.2016.01.029_bb0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216301028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216301028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T22:25:33Z","timestamp":1531952733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216301028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":37,"alternative-id":["S8756328216301028"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.01.029","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}